Found 15 matching trials
Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients
PHASE4The purpose of the study was to evaluate the effect of arginine/lysine solu...
Location
Istituto Europeo di Oncologia
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
PHASE1This study will evaluate the safety and efficacy of Lutathera (177Lu-DOTATA...
Location
Children's Hospital Colorado
Comparison of Adjuvant Treatment With 177Lu-DOTATATE to Best Supportive Care in Patients After Resection of Neuroendocrine Liver Metastases
PHASE2An international multi-centre, open, randomised, parallel-group phase II st...
Location
Imperial College Healthcare NHS Trust
A Post Marketing Surveillance on Lutathera® in Patients With Somatostatin Receptor Positive Gastroenteropancreatic Neuroendocrine Tumor in Korea
N/AThis is a prospective, open-label, multi-center, non-comparative, non-inter...
Location
Novartis Investigative Site
Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases
PHASE2This pilot phase II trial studies how effective pembrolizumab and liver-dir...
Location
University of California, San Francisco
Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed Indications
PHASE2This study is a phase 2, open, single-site trial. The primary objective of ...
Location
Multiple Locations
Retrospective Analysis of Patients Re-treated With Lutetium-177 DOTATATE (Lutathera®)
N/AThis was a retrospective non-interventional study evaluating the medical re...
Location
Excel Diagnostics & Nuclear Oncology Center
Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in GEP-NETs
N/AThis is a multicentre long-term non-interventional study of adult subjects ...
Location
Novartis Investigative Site
A Clinical Trial Evaluating the Safety of Combining Lutathera(R) and Azedra(R) to Treat Mid-gut Neuroendocrine Tumors
PHASE1This study is designed to identify the best tolerated doses of Lutathera® a...
Location
Holden Comprehensive Cancer Center
Using Novel Imaging to More Safely Treat Neuroendocrine Tumors
PHASE1The goal of this research is to determine if DetectnetTM PET/CT can be used...
Location
University of Wisconsin - Madison